Bronchiectasis

References

• Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46(6):1805–1807. doi:10.1183/13993003.00954-2015.
   PubMed Web of Science ®Google Scholar
• Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1–69. doi:10.1136/thoraxjnl-2018-212463.
   Web of Science ®Google Scholar
• Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. doi:10.1183/13993003.00629-2017.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6(9):715–726. doi:10.1016/S2213-2600(18)30053-5.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med. 2020;20(1):15. doi:10.1186/s12890-020-1050-0.
   PubMed Web of Science ®Google Scholar
• Huang HY, Chung FT, Lo CY, et al. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016. BMC Pulm Med. 2020;20(1):45. doi:10.1186/s12890-020-1080-7.
   PubMed Web of Science ®Google Scholar
• Shi L, Wei F, Ma T, Zhou W, Li M, Wan Y. Impact of Radiographic Bronchiectasis in COPD. Respir Care. 2020;65(10):1561–1573. doi:10.4187/respcare.07390.
   Web of Science ®Google Scholar
• Carreto L, Morrison M, Donovan J, et al. Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis. Thorax. 2020;75(7):592–593. doi:10.1136/thoraxjnl-2019-214195.
   PubMed Web of Science ®Google Scholar
• Oriano M, Gramegna A, Terranova L, et al. Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis. Eur Respir J. 2020;56(4):2000769. doi:10.1183/13993003.00769-2020.
   Web of Science ®Google Scholar
• Taylor SL, Woodman RJ, Chen AC, et al. FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. Thorax. 2017;72(4):304–310. doi:10.1136/thoraxjnl-2016-208775.
   Web of Science ®Google Scholar
• Rogers GB, van der Gast CJ, Cuthbertson L, et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax. 2013;68(8):731–737. doi:10.1136/thoraxjnl-2012-203105.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Haworth CS, Metersky ML, WILLOW Investigators, et al. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2020;383(22):2127–2137. doi:10.1056/NEJMoa2021713.
   PubMed Web of Science ®Google Scholar
• Ramsey KA, Chen ACH, Radicioni G, et al. Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med. 2020;201(6):661–670. doi:10.1164/rccm.201906-1219OC.
   PubMed Web of Science ®Google Scholar
• Perea L, Canto E, Suarez-Cuartin G, et al. A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile. Chest. 2020. doi:10.1016/j.chest.2020.11.011.
   Google Scholar
• Gao YH, Abo Leyah H, Finch S, et al. Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis. Am J Respir Crit Care Med. 2020;201(12):1499–1507. doi:10.1164/rccm.201910-1972OC.
   PubMed Web of Science ®Google Scholar
• Artaraz A, Crichton ML, Finch S, et al. Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST). Respir Res. 2020;21(1):18. doi:10.1186/s12931-019-1272-y.
   PubMed Web of Science ®Google Scholar
• Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2):536–541. doi:10.1164/ajrccm.156.2.9607083.
   PubMed Web of Science ®Google Scholar
• Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34(1):125–131. doi:10.1183/09031936.00160508.
   PubMed Web of Science ®Google Scholar
• Quittner AL, O'Donnell AE, Salathe MA, et al. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015;70(1):12–20. doi:10.1136/thoraxjnl-2014-205918.
   PubMed Web of Science ®Google Scholar
• De la Rosa Carrillo D, Olveira C, Garcia-Clemente M, et al. COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective Study. Chest. 2020;157(4):824–833. doi:10.1016/j.chest.2019.08.1916.
   PubMed Web of Science ®Google Scholar
• Crichton ML, Dudgeon EK, Shoemark A, Chalmers JD. Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure. Eur Respir J. 2020. doi:10.1183/13993003.03156-2020.
   Google Scholar
• Smith D, Du Rand I, Addy CL, et al. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. Thorax. 2020;75(5):370–404. doi:10.1136/thoraxjnl-2019-213929.
   PubMed Web of Science ®Google Scholar
• Crichton ML, Lonergan M, Barker AF, et al. Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies. Eur Respir J. 2020;56(1):2000608. doi:10.1183/13993003.00608-2020.
   Web of Science ®Google Scholar
• Sangiovanni S, Morales EI, Fernandez-Trujillo L. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Respir Med. 2020;176:106283 doi:10.1016/j.rmed.2020.106283.
   Web of Science ®Google Scholar
• Loebinger MR, Polverino E, Chalmers JD, et al. Efficacy and safety of TOBI Podhaler(R) in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study. Eur Respir J. 2021;57(1):2001451. doi:10.1183/13993003.01451-2020.
   Web of Science ®Google Scholar
• Basavaraj A, Choate R, Addrizzo-Harris D, et al. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry. Chest. 2020;158(4):1376–1384. doi:10.1016/j.chest.2020.06.050.
   Web of Science ®Google Scholar
• Barto TL, Maselli DJ, Daignault S, et al. Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis. Ther Adv Respir Dis. 2020;14:175346662093250. 1753466620932508. doi:10.1177/1753466620932508.
   Web of Science ®Google Scholar
• Xie B, Liu P, Wu Q, Xiang W. The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies. Am J Emerg Med. 2020;38(12):2713–2717. doi:10.1016/j.ajem.2020.08.042.
   Web of Science ®Google Scholar